Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Study highlights new therapeutic option for nocturnal hypoventilation

  • Comment

A recent study published in the journal Thorax has suggested that high-intensity non-invasive positive pressure ventilation (NPPV) is more effective at controlling nocturnal hypoventilation in COPD patients than conventional low-intensity NPPV.

The study aimed to determine whether the the novel approach of high-intensity NPPV is more effective than the conventional low-intensity NPPV at controlling nocturnal hypoventilation in patients with stable hypercapnic COPD.

The trial looked at 6 weeks of high-intensity NPPV performed in 17 patients with severe stable hypercapnic COPD.

The results showed that high-intensity NPPV is better tolerated by patients with severe chronic hypercapnic COPD and is superior to the conventional and widely-used form of low-intensity NPPV in controlling nocturnal hypoventilation. High-intensity NPPV therefore offers a new promising therapeutic option for these patients.

Click here to read the abstract of this study.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs